Minimizing steroid use in pediatric kidney recipients

Pediatric Transplantation

Volumn 15, Issue 1, 2011, Pages 32-36

  Grenda, Ryszard ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

immunosuppressives; pediatric transplantation; steroid minimization steroid sparing

Indexed keywords

ANTIDIABETIC AGENT; AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ARTICLE; AVASCULAR NECROSIS; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CUSHINGOID SYNDROME; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; FRACTURE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; GROWTH DISORDER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; PEDIATRICS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RISK REDUCTION; SIDE EFFECT; STEROID THERAPY; TREATMENT DURATION; TREATMENT WITHDRAWAL;

ACUTE KIDNEY INJURY; BIOPSY; CYCLOSPORINE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MULTICENTER STUDIES AS TOPIC; PEDIATRICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEROIDS; TACROLIMUS; TREATMENT OUTCOME;

EID: 78751656252     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01440.x     Document Type: Article

References (25)

1. Del Castillo D,. Analysis of primary and recurrent rejection following renal transplantation in a large, comparative, multicentre trial. Transplant Proc 2001: 33: 1259-1261.
2. Sperschneider H,. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation. Transplant Proc 2001: 33: 1279-1281.
3. Trompeter R, Filler G, Webb NJ, et al. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol 2002: 17: 141-149.
4. Filler G, Webb NJ, Milford DV, et al. Four-year data after pediatric renal transplantation: A randomized trial of tacrolimus vs. cyclosporin microemulsion. Pediatr Transplant 2005: 9: 498-503.
5. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) 2008 Annual Report. Renal transplantation, dialysis, chronic renal insufficiency. Available at: https://web.emmes.com/study/ped/annlrept/ Annual%20Report%20-2008.pdf (accessed 19 November 2009).
6. Kahan BD, Rajagopalan PR, Hall M,. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group. Transplantation 1999: 67: 276-284.
7. Nashan B, Moore R, Amlot P, et al. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet 1997: 350: 1193-1198.
8. Vincenti F, Kirkman R, Light S, et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med 1998: 338: 161-165.
9. Offner G, Broyer M, Niaudet P, et al. A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients. Transplantation 2002: 74: 961-966.
10. Pape L, Strehlau J, Henne T, et al. Single centre experience with basiliximab in paediatric renal transplantation. Nephrol Dial Transplant 2002: 17: 276-280.
11. Swiatecka-Urban A, Garcia C, Feuerstein D, et al. Basiliximab induction improves the outcome of renal transplants in children and adolescents. Pediatr Nephrol 2001: 16: 693-696.
12. Grenda R, Watson A, Vondrak K, et al. A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. Am J Transplant 2006: 6: 1666-1672.
13. Webb NJ, Prokurat S, Vondrak K, et al. Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: Two-year follow-up data. Pediatr Nephrol 2009: 24: 177-182.
14. Sarwal M, Pascual J,. Immunosuppression minimization in pediatric transplantation. Am J Transplant 2007: 7: 2227-2235.
15. Oberholzer J, John E, Lumpaopong A, et al. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients. Pediatr Transplant 2005: 9: 456-463.
16. Sarwal MM, Vidhun JR, Alexander SR, et al. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003: 76: 1331-1339.
17. Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001: 72: 13-21.
18. Motoyama O, Hasegawa A, Ohara T, et al. A prospective trial of steroid withdrawal after renal transplantation treated with cyclosporine and mizoribine in children: Results obtained between 1990 and 2003. Pediatr Transplant 2005: 9: 232-238.
19. Silverstein DM, Aviles DH, Leblanc PM, Jung FF, Vehaskari VM,. Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients. Pediatr Transplant 2005: 9: 589-597.
20. Hamiwka LA, Burns A, Bell L,. Prednisone withdrawal in pediatric kidney transplant recipients on tacrolimus-based immunosuppression: Four-year data. Pediatr Transplant 2006: 10: 337-344.
21. Delucchi A, Valenzuela M, Ferrario M, et al. Early steroid withdrawal in pediatric renal transplant on newer immunosuppressive drugs. Pediatr Transplant 2007: 11: 743-748.
22. Hocker B, Weber LT, Feneberg R, et al. Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil. Transplantation 2009: 87: 934-941.
23. Grenda R, Watson A, Trompeter R, et al. A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: The TWIST Study. Am J Transplant 2010: 10: 828-836.
24. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713-723.
25. Sarwal M, Benfield M, Ettinger R, et al. One year results of a prospective, randomized, multicenter trial of steroid avoidance in pediatric renal transplantation. Pediatr Transplant 2009: 13: 63.